Medicinal cannabis in Australia is not sold through general retail channels.
Access is regulated and requires a prescription issued by a registered medical practitioner.

All prescribing occurs within national frameworks designed to support appropriate clinical decision-making and patient safety.
To better understand how access works in Australia, it is useful to review how these pathways are structured.

ACCESS FRAMEWORK

Medicinal cannabis is accessed through structured pathways rather than direct sale.

These pathways include:

• Special Access Scheme (SAS)

• Authorised Prescriber pathways

These systems ensure that prescribing decisions are made based on individual clinical assessment and regulatory oversight.

Patients seeking clarity often begin by exploring medicinal cannabis access pathways in Australia to understand how these frameworks operate.

CLINICAL ASSESSMENT

A qualified practitioner will review:

• medical history

• current treatments

• overall health considerations

This assessment forms part of a structured consultation process used to determine whether this approach may be appropriate.

TELEHEALTH ACCESS

Consultations may take place via telehealth, allowing patients across Australia to connect with practitioners remotely.

This supports a consistent and regulated consultation pathway, regardless of location.

UNDERSTANDING THE PROCESS

Before proceeding, it can be helpful to review how consultations are conducted and how practitioners assess suitability within a regulated framework.

You can learn more about the consultation process for medicinal cannabis to better understand what is involved.

LEARN HOW ACCESS WORKS

Understanding the consultation and prescribing pathway can help clarify how access is managed in Australia.